STAA Staar Surgical Co

Price (delayed)

$155.03

Market cap

$7.27B

P/E Ratio

674.04

Dividend/share

N/A

EPS

$0.23

Enterprise value

$7.12B

Highlights
Staar Surgical's equity has increased by 30% YoY and by 9% QoQ
STAA's quick ratio is up by 19% QoQ and by 12% YoY
Staar Surgical's net income has soared by 87% from the previous quarter but it has decreased by 12% YoY
Staar Surgical's EPS has surged by 77% QoQ but it has decreased by 21% YoY
STAA's P/E is 31% above its last 4 quarters average of 428.5

Key stats

What are the main financial stats of STAA
Market
Shares outstanding
46.9M
Market cap
$7.27B
Enterprise value
$7.12B
Valuations
Price to earnings (P/E)
674.04
Price to book (P/B)
33.71
Price to sales (P/S)
40.37
EV/EBIT
450.36
EV/EBITDA
374.65
EV/Sales
39.76
Earnings
Revenue
$179.03M
EBIT
$15.81M
EBITDA
$19M
Free cash flow
$27.51M
Per share
EPS
$0.23
Free cash flow per share
$0.59
Book value per share
$4.6
Revenue per share
$3.84
TBVPS
$5.66
Balance sheet
Total assets
$265.81M
Total liabilities
$51.63M
Debt
$10.13M
Equity
$214.18M
Working capital
$187.39M
Liquidity
Debt to equity
0.05
Current ratio
6.19
Quick ratio
5.43
Net debt/EBITDA
-8.01
Margins
EBITDA margin
10.6%
Gross margin
74.1%
Net margin
6.2%
Operating margin
8.5%
Efficiency
Return on assets
4.5%
Return on equity
5.7%
Return on invested capital
20.8%
Return on capital employed
6.9%
Return on sales
8.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STAA stock price

How has the Staar Surgical stock price performed over time
Intraday
20.41%
1 week
21.27%
1 month
7.12%
1 year
150.82%
YTD
95.7%
QTD
1.66%

Financial performance

How have Staar Surgical's revenue and profit performed over time
Revenue
$179.03M
Gross profit
$132.74M
Operating income
$15.29M
Net income
$11.04M
Gross margin
74.1%
Net margin
6.2%
STAA's operating income has surged by 126% since the previous quarter and by 67% year-on-year
Staar Surgical's operating margin has soared by 107% from the previous quarter and by 42% YoY
Staar Surgical's net income has soared by 87% from the previous quarter but it has decreased by 12% YoY
Staar Surgical's net margin has soared by 72% from the previous quarter but it has decreased by 24% YoY

Growth

What is Staar Surgical's growth rate over time

Valuation

What is Staar Surgical stock price valuation
P/E
674.04
P/B
33.71
P/S
40.37
EV/EBIT
450.36
EV/EBITDA
374.65
EV/Sales
39.76
Staar Surgical's EPS has surged by 77% QoQ but it has decreased by 21% YoY
STAA's P/E is 31% above its last 4 quarters average of 428.5
STAA's price to book (P/B) is 110% higher than its 5-year quarterly average of 13.3 and 57% higher than its last 4 quarters average of 17.8
Staar Surgical's equity has increased by 30% YoY and by 9% QoQ
The stock's price to sales (P/S) is 199% more than its 5-year quarterly average of 11.2 and 57% more than its last 4 quarters average of 21.3
The revenue has grown by 17% YoY and by 10% from the previous quarter

Efficiency

How efficient is Staar Surgical business performance
The ROIC has soared by 89% from the previous quarter and by 37% YoY
The ROE has soared by 73% from the previous quarter but it has contracted by 30% YoY
Staar Surgical's return on assets has surged by 73% QoQ but it has decreased by 29% YoY
Staar Surgical's return on sales has surged by 73% QoQ and by 40% YoY

Dividends

What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STAA.

Financial health

How did Staar Surgical financials performed over time
The total assets is up by 29% year-on-year and by 3.3% since the previous quarter
Staar Surgical's total liabilities has increased by 23% YoY but it has decreased by 14% from the previous quarter
Staar Surgical's debt is 95% less than its equity
Staar Surgical's equity has increased by 30% YoY and by 9% QoQ
Staar Surgical's debt has increased by 24% YoY but it has decreased by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.